| 11/13/2026 3:08 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/13/2026 3:11 PM | VistaGen Therapeutics (1411685) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/09/2026 7:34 AM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2026 4:24 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/09/2026 4:15 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/25/2026 8:11 AM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/24/2026 6:05 AM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/22/2026 3:22 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 4:49 PM | ORBIMED ADVISORS LLC (1055951) Filed by VistaGen Therapeutics (1411685) Subject | Form SCHEDULE 13G/A | |
| 08/14/2026 3:04 PM | Commodore Capital LP (1831942) Filed by VistaGen Therapeutics (1411685) Subject | Form SCHEDULE 13G/A | |
| 08/14/2026 7:40 AM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for VTGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for VistaGen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/06/2026 3:16 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/31/2026 3:10 PM | VistaGen Therapeutics (1411685) Filer | Form DEF 14A | |
| 07/31/2026 3:11 PM | VistaGen Therapeutics (1411685) Filer | Form DEFA14A | |
| 07/31/2026 7:53 AM | VistaGen Therapeutics (1411685) Issuer Williamson Douglas J (1911501) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/31/2026 7:56 AM | VistaGen Therapeutics (1411685) Issuer Williamson Douglas J (1911501) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/31/2026 7:48 AM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/02/2026 3:34 PM | Adler Reid G. (1924908) Reporting VistaGen Therapeutics (1411685) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 3:17 PM | Tressler Nick B. (1794362) Reporting VistaGen Therapeutics (1411685) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 7:28 AM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/17/2026 4:13 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/15/2026 3:50 PM | VistaGen Therapeutics (1411685) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 06/15/2026 3:35 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/09/2026 4:04 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/19/2026 3:51 PM | Angelov Angel S (2132062) Reporting VistaGen Therapeutics (1411685) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/19/2026 3:52 PM | Angelov Angel S (2132062) Reporting VistaGen Therapeutics (1411685) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2026 6:44 AM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/13/2026 4:27 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/09/2026 7:40 PM | Prince Joshua S. (1998663) Reporting VistaGen Therapeutics (1411685) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/09/2026 7:41 PM | Singh Shawn (1412071) Reporting VistaGen Therapeutics (1411685) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/09/2026 7:43 PM | Tressler Nick B. (1794362) Reporting VistaGen Therapeutics (1411685) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/09/2026 7:33 PM | Adler Reid G. (1924908) Reporting VistaGen Therapeutics (1411685) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/09/2026 7:38 PM | Cote Elissa S. (2069951) Reporting VistaGen Therapeutics (1411685) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 3:45 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/16/2026 3:10 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/11/2026 6:02 AM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/20/2026 8:12 AM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 5:33 PM | ORBIMED ADVISORS LLC (1055951) Filed by VistaGen Therapeutics (1411685) Subject | Form SCHEDULE 13G/A | |
| 02/17/2026 11:35 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by VistaGen Therapeutics (1411685) Subject | Form SCHEDULE 13G/A | |
| 02/06/2026 3:12 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/30/2026 1:47 PM | VANGUARD GROUP INC (102909) Filed by VistaGen Therapeutics (1411685) Subject | Form SCHEDULE 13G/A | |
Buy Stocks… A Crash is Coming (Ad) Think stocks are expensive and a crash is coming? Economist Jim Rickards says you're right, but he urges investors not to sell before hearing his 2027 prediction.
He warns that by November 30th, Congress is set to make a move he believes will trigger a historic buying panic. Economists call the phenomenon a crack-up boom.
Rickards is known for correctly predicting the biggest market shocks of the last 20 years. See Jim Rickards' 2027 prediction before the November 30th deadline arrives. |
| 01/09/2026 4:26 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/05/2026 7:51 PM | Prince Joshua S. (1998663) Reporting VistaGen Therapeutics (1411685) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 4:29 PM | VistaGen Therapeutics (1411685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/04/2025 5:05 AM | Tressler Nick B. (1794362) Reporting VistaGen Therapeutics (1411685) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 12/04/2025 5:07 AM | Tressler Nick B. (1794362) Reporting VistaGen Therapeutics (1411685) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |